Carcinoma, Thymic: Clinical Trials

2 trials for Carcinoma, Thymic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow Carcinoma, Thymic: new trials by email Literature Review of Carcinoma, Thymic trials Research Report on Carcinoma, Thymic

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Investigate the Efficacy and Safety of Atezolizumab (Tecentriq) in Previously-Treated Patients With Advanced Thymic Carcinoma
Atezolizumab - Carcinoma, Thymic
Phase 2CompletedHoffmann-La Roche342020-08-072024-06-11
Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies
AZD6244, MK-2206, Lapatinib - Carcinoma, Non-Small-Cell Lung, Carcinoma, Small Cell Lung
Phase 2CompletedNational Cancer Institute (NCI)6472011-02-082024-10-01

Narrower conditions

Thymoma (2)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Small Cell Lung Carcinoma (1)

Broader conditions

Hemic and Lymphatic Diseases (2)  ·  Lymphatic Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms by Site (2)  ·  Neoplasms, Complex and Mixed (2)  ·  Thoracic Neoplasms (2)  ·  Thymus Neoplasms (2)  ·  Bronchial Neoplasms (1)  ·  Carcinoma, Bronchogenic (1)  ·  Lung Diseases (1)  ·  Lung Neoplasms (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Neoplasms (1)

Interventions

AZD 6244 (1)  ·  Erlotinib Hydrochloride (1)  ·  Lapatinib (1)  ·  MK 2206 (1)  ·  Sunitinib (1)  ·  atezolizumab (1)

Sponsors

Hoffmann-La Roche (1)  ·  National Cancer Institute (NCI) (1)

Countries

China (1)  ·  United States (1)

Top investigators

Arun Rajan, M.D. (1)

Results publications

PMID 25667274, PMID 26028668, PMID 34393061